// App-Quantinova.ai

1081 : Value of EVI1 Gene Expression Level in Adult Acute Lymphoblastic Leukemia (ALL): A Study from the Group for Research on Adult ALL (GRAALL)

Researchers

Presenter

  • Claire Abbal

Principal Investigators

  • Raouf Ben Abdelali

  • Marina Lafage

  • Nathalie Grardel

  • Anne Bouvier

  • Michel Duchosal

  • Francoise Huguet

  • Thibaut Leguay

  • Olivier Spertini

  • Nicolas Boissel

  • Claude Gardin

  • Carlos Graux

  • Jean-Michel Cayuela

  • Marie-Laure Boulland

Medical Centers

  • Cytogenetics, CHU Timone, Marseille, France

  • Coordination, Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL), Lyon, France

  • Neuroradiology, CHUV, Lausanne, Switzerland

  • Institut Claudius Regaud, Service dHematologie, Toulouse, France

  • Service dHematologie et de Therapie Cellulaire, University Hospital of Bordeaux, Pessac, France

  • Laboratoire dhematologie, Centre de biologie pathologie, CHU Lille, Lille, France

  • Hematology, CHU, Angers, France

  • Hematology Laboratory, Hopital Saint-Louis, AP-HP, Paris, France

  • Laboratoire dHematologie, Hopital Saint-Louis, AP-HP, Universite Paris Diderot, Paris, France

  • CHU UCL de Mont-Godinne, Yvoir, Belgium

  • Neuroradiology, CHUV, Lausanne, Switzerland

  • Hopital Sud (CHU), Rennes, France

  • Hospital Saint Antoine, Paris, France

  • CHU, Angers, France

Locations

  • France

  • Switzerland

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • rAAV2/5-PBGD

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final